IRS-4 could be involved in this process, favoring tumor proliferation in certain areas and decreasing the invasive capacity on the invasive front of the tumor, which could explain the phenomenon of patients with a lower proportion of IRS-4 and Ki-67 having a greater number of foci. The gene discussed is IRS4; the disease is neoplasm.